Barometer Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-16,500
Closed -$5.17M 146
2017
Q3
$5.17M Buy
+16,500
New +$4.89M 0.5% 61
2016
Q4
Sell
-25,500
Closed -$7.98M 131
2016
Q3
$7.98M Buy
+25,500
New +$7.55M 0.89% 41
2015
Q2
Sell
-11,358
Closed -$4.8M 162
2015
Q1
$4.8M Buy
11,358
+858
+8% +$338K 0.37% 52
2014
Q4
$3.56M Sell
10,500
-3,100
-23% -$1M 0.31% 49
2014
Q3
$4.5M Buy
+13,600
New +$4.48M 0.36% 47
2014
Q2
Sell
-1,900
Closed -$581K 99
2014
Q1
$581K Buy
+1,900
New +$603K 0.13% 82

Other funds holding BIIB

Barometer Capital Management's BIIB Position: Q4 2017 in Review

Barometer Capital Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 16,500 shares — an estimated $5.17M sold.

Barometer Capital Management first reported a position in BIIB in Q1 2014 and held it in 6 quarters. The position peaked at $7.98M in Q3 2016. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Barometer Capital Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Barometer Capital Management sold 16,500 Biogen shares in Q4 2017, an estimated $5.17M.
  • Barometer Capital Management first reported a position in Biogen in Q1 2014 and held it in 6 quarters.
  • Barometer Capital Management's Biogen position peaked at $7.98M in Q3 2016.
  • 1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Barometer Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.